Medical Marijuana, Inc. (MJNA)
- Previous Close
0.0020 - Open
0.0020 - Bid --
- Ask --
- Day's Range
0.0020 - 0.0022 - 52 Week Range
0.0009 - 0.0075 - Volume
335,525 - Avg. Volume
18,347,619 - Market Cap (intraday)
56.488M - Beta (5Y Monthly) 1.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 20, 2024 - May 24, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products. The company is also involved in the research and development of new therapeutic agents that are designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants; dietary supplements, skin care products, and prescription-based hemp oil under the Kannaway and HempMeds brands; and proprietary testing, genetics, labeling and packaging, tracking, and production and standardization methods for the medicinal cannabinoid industry. In addition, it offers RSHO oil for the treatment of various illnesses and conditions; and plant-based, non-GMO pet products for health and wellness, play and wear, and environmentally-friendly supplies. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California.
www.medicalmarijuanainc.com91
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: MJNA
Performance Overview: MJNA
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MJNA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MJNA
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
1.87
Enterprise Value/EBITDA
-0.23
Financial Highlights
Profitability and Income Statement
Profit Margin
14.91%
Return on Assets (ttm)
-1.46%
Return on Equity (ttm)
12.06%
Revenue (ttm)
58.98M
Net Income Avi to Common (ttm)
8.8M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
4.68M
Total Debt/Equity (mrq)
13.43%
Levered Free Cash Flow (ttm)
632.28k
Company Insights: MJNA
MJNA does not have Company Insights